Ads
related to: undetectable psa after prostatectomy- View An Injection Video
Some Patients May Use Prefilled
Syringes. Find Self-Injection Info.
- Download A Brochure
Access A Downloadable Resource
For Talking To Your Rheumatologist.
- Unique Patient Support
Find Patient Support As Unique As
You And Access A Dedicated Nurse.
- Sign Up For Updates
Stay Informed About This Treatment
Option By Signing Up For Updates.
- View An Injection Video
Search results
Results From The WOW.Com Content Network
After prostatectomy, PSA levels drop rapidly, reaching very low or undetectable levels within two months. Radiotherapy also substantially reduces PSA levels, but more slowly and less completely, with PSA levels reaching their nadir two years after radiotherapy. [53] After either treatment, PSA levels are monitored regularly.
Biochemical recurrence is a rise in the blood level of prostate-specific antigen (PSA) in prostate cancer patients after treatment with surgery or radiation. Biochemical recurrence may occur in patients who do not have symptoms. It may mean that the cancer has come back. Also called PSA failure and biochemical relapse. [1]
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene.PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.
After surgery or radiation therapy, PSA may start to rise again, which is called biochemical recurrence if a certain threshold is met in PSA levels (typically 0.1 or 0.2 ng/ml for surgery). At 10 years of follow-up after surgery, there is an overall risk of biochemical recurrence of 30–50%, depending on the initial risk state, and salvage ...
The actor, who is best known for his work on shows like "All My Children" and "Melrose Place," shared in an Instagram post Thursday that he had recently undergone surgery for prostate cancer.
Richard J. Ablin (May 15, 1940 – October 6, 2023) [1] was an American scientist, most notable for research on prostate cancer.According to the Wall Street Journal: . Richard Ablin, a professor of pathology at University of Arizona College of Medicine, discovered the prostate-specific antigen (PSA) in 1970, and for nearly as long, he has argued that it should not be used for routine screening.